Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.8%

7 terminated/withdrawn out of 388 trials

Success Rate

92.6%

+6.1% vs industry average

Late-Stage Pipeline

12%

48 trials in Phase 3/4

Results Transparency

5%

4 of 88 completed trials have results

Key Signals

97 recruiting4 with results5 withdrawn

Enrollment Performance

Analytics

N/A
131(54.8%)
Phase 2
42(17.6%)
Phase 4
27(11.3%)
Phase 3
21(8.8%)
Phase 1
10(4.2%)
Early Phase 1
8(3.3%)
239Total
N/A(131)
Phase 2(42)
Phase 4(27)
Phase 3(21)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (388)

Showing 20 of 388 trials
NCT06434649Not ApplicableActive Not Recruiting

Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer

Role: collaborator

NCT07249632Phase 3Recruiting

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

Role: collaborator

NCT07519798Not ApplicableEnrolling By Invitation

Effects of Transcranial Temporal Interference Stimulation on Cognitive Function in Mild Cognitive Impairment

Role: collaborator

NCT06704074Not ApplicableRecruiting

Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients

Role: collaborator

NCT07364487Early Phase 1Withdrawn

This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis

Role: lead

NCT05620095Recruiting

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

Role: collaborator

NCT05020106Recruiting

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Role: collaborator

NCT04850053Recruiting

Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Role: collaborator

NCT07482020Phase 2Recruiting

SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

Role: lead

NCT07466329Completed

Research and Validation of a Big Data-Driven Intelligent Decision-Making System for Hemodialysis

Role: lead

NCT07469735Not ApplicableNot Yet Recruiting

Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma

Role: lead

NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT07466251Phase 4Not Yet Recruiting

PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

Role: collaborator

NCT07353463Recruiting

Shanghai Clinical Cohort - Parkinson's Disease (Reserve)

Role: collaborator

NCT07442422Not ApplicableCompleted

Endocare Repair Efficacy Skincare Products in the Use of Post-laser Treatment

Role: lead

NCT07434518Recruiting

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Role: collaborator

NCT04698304Active Not Recruiting

The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT06153069Phase 4Recruiting

Asymptomatic TB With Innovative Modified Short-course Regimens

Role: lead